Ten metabolites produced by 4 mutants derived from Actinomadura verrucosospora subsp. neohibisca E-40, a high pradimicins producer, were isolated and their structures were determined.
Ten metabolites produced by 4 mutants derived from Actinomadura verrucosospora subsp. neohibisca E-40, a high pradimicins producer, were isolated and their structures were determined.
Strain JN-219 produced 3 novel analogs of the pradimicin A aglycone, i.e. ll-O-demethyl-7-methoxypradinone II and 1 1-O-demethylpradinones I and II together with a known aglycone analog, pradinone I, while the metabolites from strain JN-47 were determined to be 2 new aglycone analogs, 1 1-0-demethylpradimicinone I and 1 l -O-demethyl-7-methoxypradimicinone II and a known aglycone analog, 1 1-O-demethylpradimicinone II (l ldM-PMNII). Products of strain JN-207 were identified as l l-O-demethyl-6-deoxypradinone I and l ldM-PMNII. Interestingly, a new pradimicin analog, 7-hydroxypradimicin A was isolated from strain JN-58 together with a new aglycone analog, pradimicinone II and l ldM-PMNII. None of these metabolites showed antifungal activity.
In order to elucidate the subunit assembly of pradimicin biosynthesis in Actinomadura verrucosospora subsp. neohibisca E-40, we have generated 37 mutants blocked in the pradimicins production and selected 
Materials and Methods
Strain Strains JN-47, JN-58, JN-207 and JN-219 used in this study are blocked mutants derived from A. verrucosospora subsp. neohibisca E-40, a pradimicin A high-producing strain1*. They were propagated on yeast -starch agar composed of yeast extract (Difco Laboratories Inc.) 0.2%, soluble starch 1 % and agar 1.8% under incubation at 28°C for 2 weeks. For preparation of the vegetative inoculum and the production of metabolites, the FR-18 medium was used, refer1*.
Fermentation
Mature spores of each slant culture were inoculated into a 500-ml Erlenmeyer flask containing 100 ml of the FR-18 mediumand cultivated at 32°C for 6 days on a rotary shaker. Then, the resulting vegetative inoculum was transferred to 100ml of the FR-18 medium prepared in 500-ml Erlenmeyer flasks and fermented at 28°C for 10 days on a rotary shaker. Products were analyzed by TLCand HPLC1}. PN I (9), PMNI (10) and lldM-PMN II (ll) were reported as dealanylpradimicinone (AG-3)2'3), pradimicinone (AG-2)2>3) and pradimicin P3), respectively.
General
UVand IR spectra were recorded on a Shimadzu UV-260 spectrophotometer and an Analect JIR-fx6160 spectrophotometer, respectively. FAB-MSspectra were measured on a JEOLJMS-AX505H with 5keV beamof energetic xenon atoms and 3 kV as an acceleration voltage using raeta-nitrobenzyl alcohol as a matrix. MP's were determined with a Yanaco MP-3Smicro melting point apparatus and are uncorrected. *H and 13C NMRspectra were recorded on a JEOL JNM-GX 400 spectrometer with DMSO-d6 as an internal reference. The CDspectra were measured in methanol on a JASCOJ-600 spectrometer.
Results

Fermentation
The strain JN-219 produced 4 analogs of pradimicin A aglycone, named 1 1-O-demethylpradinones I and II (lldM-PN I, 3 and lldM-PN II, 1), ll-O-demethyl-7-methoxypradinone II (lldM-7M-PN II, 2) and pradinone I (PN I, 9), the strain JN-47 produced 3 aglycone analogs, designated ll-0-demethyl- Erlenmeyer flasks each containing 100ml of the FR-18 mediumwere used to produce 4~5 liters of individual broths for isolation of these metabolites. The progress of fermentations was monitored by checking the visible adsorption3) and HPLCanalysis1*. The metabolites production in these 4 strains reached maximumat day 10 fermentation, and their titers are summarized in Table 1 .
Isolation
Metabolites accumulated by 4 mutants, strains JN-219, JN-47, JN-58 and JN-207, were easily isolated from the cultured broths with Diaion HP-20 and purified by solvent extraction and/or acidic precipitation, followed by a reverse phase silica gel column chromatography (YMCODS-A60,YamamuraChemical Lab. Ltd.). Fig. 2 summarized a typical example for the isolation of compounds 1, 2, 3 and 9 produced by the strain JN-219. The fermentation broth was centrifuged at 5,000rpm for 10 minutes. The products in the supernatant (4.5 liters) were adsorbed on 3.5 liters of Diaion HP-20, washed with water (5 liters) and eluted with 60% aq acetone. The eluted fractions (10ml each) were monitored by silica gel TLCas described previously1}, and the 4 fractions containing each desired products were pooled and concentrated in vacuo. Fraction I (400ml) was extracted with a mixture of butanol (300ml) and methanol (100ml) at pH2. The solvent layer was re-extracted with alkaline water (100 ml) at pH8. This water layer was acidified to pH 2.4 with 6n HC1and centrifuged to remove compound1. The supernatant thus obtained was neutralized, concentrated to dryness and then applied to a YMC ODS-A60 column chromatography, followed by preparative HPLCto yield compound 2 (45 mg). The acid precipitates of both fractions I and II were combined and purified by an ODScolumn chromatography to give compound 1 (4.5 g). The acid precipitates of fractions III and IV were rechromatographed on an ODScolumn to afford compound3 (720 mg) and compound 9 (51 mg), respectively.
By a similar procedure, compounds 4 (592mg), 5 (302mg) and ll (1.29g) were isolated from the broth (4.5 liters) of strain JN-47. Compounds 6 (750mg), 8 (227mg) and ll (151 mg) were obtained from the strain JN-58 (4 liters). Compounds ll (1.53g) and 7 (324mg) were isolated from the strain JN-207 (4.5 liters). Among them, compounds 9 and ll were identified as dealanylpradimicinone (AG-3)2)3) and pradimicin P3), respectively, based on the direct comparison.
Physico-chemical Properties
The physico-chemical properties of compounds 1~8 are summarized in Table 2 . They are orange-red, amorphous powders, which are readily soluble in dimethyl sulfoxide and Af,7V-dimethylformamide and slightly soluble in methanol, ethanol, and alkaline water, but insoluble in other organic solvents and acidic water. The molecular formulae of these compounds were established as shown in Table 2 by positive-or negative-ion HRFAB-MS. The UVand visible adsorption spectra of these compoundsunder acidic and alkaline conditions are consistent with the chromophore of the pradimicin family of antibiotics, indicating that they have a polyhydroxy-5,6-dihydrobenzo[«]naphthacenequinone skeleton. This is supported by the IR absorption band at around 1599~1618cm"1 due to the stretching of the quinonecarbonyl hydrogen-bonded with the /?en-hydroxyl4). The presence of an amido carbonyl group at around 1660 cm" 1 in the IR spectra of4, 5, 6 and 8, and the detection of a characteristic fragment ion (M-88)+ due to the cleavage of alanine in the FAB-MSindicate that these compounds have an alanine moiety bonded to the chromophore. Alanine in 4, 5, 6 and 8 was determined to have the jR-configuration based on the HPLC mobility of their hydrolysis products by a chiral column method as previously reported2). Structure The structures of the compounds 1~8 were determined by a combination of two dimensional 1H-1H Chemical shifts are expressed by S (ppm), multiplicity is in parentheses.
Structures
of lldM-7M-PN II (2), lldM-7M-PMN II (5) and PMN II (6) The protonated molecular ions of 2 (m/z 495) and 5 (m/z 566) in the FAB-MSspectra are 14 mass unit higher than those of 1 and ll, respectively. When the *H NMRspectra of 2 and 5 are compared to those of 1 and ll, most protons are assigned quite similar positions, except for an additional methoxy signal, found in both 2 and 5 at 3.86ppm. Moreover, their NOESYspectra exhibit a NOEcorrelation peak between the methoxy and methine proton 6-H. Thus, the compounds 2 and 5 are the 7-methoxy analogs of 1 and ll and called ll-O-demethyl-7-methoxypradinone II (lldM-7M-PN II) and 1 1-0-7-methoxypradimicinone II (l ldM-7M-PMN II), respectively. Compound6 is closely similar to ll in UVand IR spectra. The MSof6 displays 14 mass units more than ll and one additional methoxy group (3.95ppm) is observed in *H NMR,which shows a NOEto two aromatic protons 10-H and 12-H. Hence, the structure of 6 is assigned as ll-methoxy analog of ll and named pradimicinone II (PMNII). The NMRdata (/5>6=~3.0Hz) as shown in Table 3 Structure of HdM-6dO-PNI (7) The FAB-MSspectra of compound 7 reveal a protonated ion at m/z 449 with the characteristic fragment ions at m/z 431 and 413, which show 16 mass units lower than the corresponding ions of 3. If the *H NMRspectrum of 7 is compared with compound3, three proton signals, a methine at 4.57ppm and methylene protons at 2.75 and 3.1.1 ppm (corresponding to a methine at 69.6ppm and methylene carbon at 29.0ppm, respectively, by the 13C-1H COSYexperiment) appear as each a doublet of doublets (AMXspin system) whereas these are two methine signals for 5-H and 6-H in 3. NOEsin 7 are observed between the methine proton (4.57ppm) and 4-H, and one of the methylene protons (3.ll ppm) and 7-H. MAR. 1993 This indicates that a methine proton is assignable to 5-H and methylene protons at C-6. The vicinal coupling constant values between the methine at C-5 position and methylene protons at C-6, are 4.7 Hz and 9.8Hz, indicating that the hydroxy group at C-5 of 7 is in the equatorial orientation. From these results, the structure of 7 is determined to be 6-deoxy analog of 3 and named ll-O-demethyl-6-deoxypradirione I (HdM-6dO-PN I).
Structure of 7OH-PRMA (8) In the FAB-MSspectra of 8, the pseudomolecular ions at m/z 857 (M+H)+ and 879 (M+Na)+ appear together with the characteristic fragment ions at m/z 768 resulting from a loss of alanine moiety, m/z 725 (M-xylose)+, 548 (carbonium ion of 6), m/z 477, 459 and 443 due to the aglycone of 6 and oxonium ions of sugar parts at m/z 292 (disaccharide) and 160 (Af-methylthomosamine). These data suggest that 8 is composed of the aglycone 6 and xylosyl-N-methylthomosamine, the same sugar moiety as in pradimicin A (12). The structure is further confirmed by comparing the acid hydrolysis products and NMR data of 8 and 12. Upon acid hydrolysis, 8 afforded aglycone 6, xylose and ninhydrin positive substances, and these degradation products except for 6 are identical with the hydrolysates of 12 on TLC. The NMR data for compound 8 assigned by double quantum filter COSY, relayed COSY, heteronuclear COSYand COLOCexperiments, are summarized in Table 5 . Except for 5-H, 6-H (/= 3.0 Hz) and disappearance of H-7, these data for 8 closely correspond to those of 12, particularly in the sugar moiety. In the rotating frame Nuclear Overhauser Effect (ROESY) and NOESYspectra of 8, NOEcorrelation peaks display between l'-H-3'-H, l'-H-5'-H, 4'-H-4'-NMe and 4-H'-6'-H in the thomosamine part and among l"-H-3"-H-axial 5"-H (3.08 ppm) in the xylose part. Moreover, NOE's peaks between H-5 and the anomeric proton of iV-methylthomosamine (l'-H) and between 3 -H and the anomeric proton of xylopyranose (1"-H) are observed in their spectra of 8. The magnitudes of coupling constants of two anomeric protons are 7.6 Hz for l'-H and 7.7 Hz for l' -H, indicating that the sugar moiety has a /?-pyranoside linkage of xylose to 3'-OH and^-linkage of C-l' to 5-OH. From the results mentioned above, the structure of 8 is composed of an aglycone 6 attached to the same disaccharide as in PRM A (12), i.e., 7-hydroxypradimicin A (7OH-PRM A). However, the geometry between C-5 and C-6 of8 is found to be trans-diaxial diol based on the coupling constants (3/H_5 H_6 = 3.0 Hz, 3^c-i4a,H-6=5.9Hz, 3/c.14b>H.5=4.4Hz). Furthermore, the CD curve of 8 [/l^L nm (As) 212 (-21.6), 238 (34.5), 282 (-6.0)] shows opposite sign to that of 12. Therefore, the stereochemistry at C-5 and C-6 of 8 are established to be (55,65) with different conformation from that of the pradimicin A (12).
Discussion
The results of this study demonstrate that the 4 strains derived from A. verrucosospora subsp. neohibisca E-40 are mutants with modified biosynthesis of pradimicins and producing 5,6-dihydrobenzo[a]naphthacenquinone chromophores with different substitution patterns. It is noted that: compounds1, 6 and ll possess a hydroxy group at C-7 position; compounds 2 and 5 possess a methoxyl group at C-7 position; and compounds 3, 4 and 9 lack a hydroxyl group at C-7 position. It is important to note that these compounds produced by 4 mutants have all (55,65) configuration, and compounds 1, 2, 5, 6, ll and 7-hydroxypradimicin A (8) have different conformation at C-5-and C-6-positions from that observed for compounds 3, 4, 7 and 9 as well as 10 and pradimicin A (12).
